Aignostics

📍 Berlin, Germany🗓 Founded 2018👥 116 employees💰 Last funded Dec 2022
Software Development🌐 aignostics.com
Website LinkedIn
Aignostics combines proprietary access to multimodal clinical datasets, industry-leading AI technologies, and rigorous science to develop best-in-class insights for the next generation of precision medicine. Through collaborations with its biopharma partners, Aignostics supports drug discovery, translational research, clinical trials, and CDx development across multiple therapeutic areas. Established in 2018, Aignostics is a spin-off from Charité Berlin, one of the world’s largest and most esteemed university hospitals. Aignostics is funded by leading VC investors and has operations in Berlin and New York.
4
Total investors
2
Early stage
2
Mid stage
0
Late stage
2018
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Germany
4
Investor activity2020–2022 · investors recorded per year
2020220222
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Aignostics?
Aignostics has 4 investors on record on gritt.io, including 2 early-stage backers, 2 mid-stage.
When did Aignostics last raise funding?
The most recent investment in Aignostics recorded on gritt.io was in December 2022.
When was Aignostics founded?
Aignostics was founded in 2018.
What industry is Aignostics in?
Aignostics operates in Software Development. Find similar Software Development investors on gritt.io.
Where is Aignostics based?
Aignostics is headquartered in Berlin, Germany.